Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine

NCT00743340 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: Emtricitabine

Sponsor

Gilead Sciences